- Episode 6 with Victoria DiBiaso | Power
Listen to this episode on:
Today’s episode features Victoria DiBiaso from Sanofi. Victoria provides a detailed analysis of patient-informed development and the critical importance of diversity and inclusion in clinical trials. With her unique perspective stemming from her nursing background, she explains the significance of patient-centric trials and the future of healthcare.
Throughout the episode, Victoria elaborates on effective communication with patient communities, the significance of trust-building, and how understanding social determinants of health can aid in forging strong relationships with patient advisors. The episode further explores the world of drug development, from considering patient-relevant endpoints to health scales and label opportunities.
Topics Discussed:
- An explanation of patient-informed development
- The meaning of patient centricity
- Stumbling blocks to patient centricity
- Cross-industry collaboration milestones
- The new voice Victoria wants to bring forward
- How to talk about clinical trials in language patients want to hear
- Important factors in implementing patient-centric solutions
- What the future of patient-centric clinical trials looks like
- What modern patient recruitment means
- How Victoria would change clinical trials overnight if she had a magic wand
- How to learn more about what Victoria is doing
Subscribe to Power's Newsletter
Stay ahead with a new patient recruitment insight every week.